PARIS (Reuters) - French drugmaker Sanofi said on Tuesday that its Zaltrap drug had been approved for marketing in the European Union to treat metastatic colorectal cancer.
The approval came after a recent late-stage study of the drug showed significant improvement in survival among patients with colon cancer.
(Reporting By Christian Plumb, Editing by Dominique Vidalon)
Source: http://news.yahoo.com/sanofi-says-zaltrap-approved-europe-colorectal-cancer-061730640--finance.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.